Exhaled Nitric Oxide

Immunology and Allergy Clinics of North America

Volumn 32, Issue 3, 2012, Pages 347-362

  Stewart, Lora ^a   Katial, Rohit K ^b  

^a Allergy and Asthma Care and Prevention Center   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Asthma; Fractional concentration of exhaled NO; Glucocorticoids; Nitric oxide

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOCORTICOID; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

AGE; AIRWAY REMODELING; ASTHMA; BIOLOGICAL ACTIVITY; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIARY DYSKINESIA; CYSTIC FIBROSIS; DRUG RESPONSE; EOSINOPHILIA; FRACTIONAL CONCENTRATION OF EXHALED NITRIC OXIDE; HUMAN; INTERMETHOD COMPARISON; INTERSTITIAL LUNG DISEASE; NORMAL VALUE; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT PARAMETERS; REVIEW; SEX DIFFERENCE; SMOKING;

EXHALATION; HUMANS; NITRIC OXIDE; RESPIRATORY TRACT DISEASES;

EID: 84864814975     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2012.06.005     Document Type: Review

References (104)

1. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
2. Gustafsson L.E., Leone A.M., Persson M.G., et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991, 181:852-857.
3. Alving K., Weitzberg E., Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993, 6:1368-1370.
4. Kharitonov S.A., Yates D., Robbins R.A., et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994, 343:133-135.
5. Persson M.G., Zetterstrom O., Agrenius V., et al. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994, 343:146-147.
6. Yates D.H., Kharitonov S.A., Robbins R.A., et al. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995, 152:892-896.
7. Kharitonov S.A., Yates D.H., Barnes P.J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996, 153:454-457.
8. Massaro A.F., Gaston B., Kita D., et al. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995, 152:800-803.
9. Dweik R., Boggs P.B., Erzurum S.C., et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels for clinical applications. Am J Respir Crit Care Med 2011, 184:602-615.
10. Ignarro L.J., Buga G.M., Wood K.S., et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987, 84:9265-9269.
11. Kerwin J.F., Heller M. The arginine-nitric oxide pathway: a target for new drugs. Med Res Rev 1994, 14:23-74.
12. Moncada S., Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
13. Silkoff P.E., Lent A., Busacker A., et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 2005, 116:1249-1255.
14. Gaston B., Kobzik L., Stamler J.S. Distribution of nitric oxide synthase in the lung. Nitric oxide and the lung 1997, 75-86. Dekker, New York. W.M. Zapol, K.D. Bloch (Eds.).
15. Ricciardolo F.L., Sterk P.J., Gaston B., et al. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004, 84:731-765.
16. Förstermann U., Schmidt H.H., Pollock J.S., et al. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 1991, 42:1849-1857.
17. Guo F.H., De Raeve H.R., Rice T.W., et al. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A 1995, 92:7809-7813.
18. Fischer A., Folkerts G., Geppetti P., et al. Mediators of asthma: nitric oxide. Pulm Pharmacol Ther 2002, 15:73-81.
19. Yates D.H. Role of exhaled nitric oxide in asthma. Immunol Cell Biol 2001, 79:178-190.
20. Belvisi M.G., Stretton C.D., Yacoub M., et al. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol 1992, 210:221-222.
21. Li C.G., Rand M.J. Evidence that part of the NANC relaxant response of guinea pig trachea to electrical field stimulation is mediated by nitric oxide. Br J Pharmacol 1991, 102:91-94.
22. Shaul P.W., North A.J., Wu L.C., et al. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest 1994, 94:2231-2236.
23. Pechkovsky D.V., Zissel G., Goldmann T., et al. Pattern of NOS2 and NOS3 mRNA expression in human A549 cells and primary cultured AEC II. Am J Physiol Lung Cell Mol Physiol 2002, 282:L684-L692.
24. Li D., Shirakami G., Zhan X., et al. Regulation of ciliary beat frequency by the nitric oxide cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells. Am J Respir Cell Mol Biol 2000, 23:175-181.
25. 2+ regulates the phosphorylation and the dephosphorylation of ciliary proteins via the NO pathway. J Gen Physiol 2004, 124:527-540.
26. Jain B., Rubinstein I., Robbins R.A., et al. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993, 191:83-88.
27. Di Rosa M., Radomski M., Carnuccio R., et al. Glucocorticosteroids inhibit the expression of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 1990, 172:1246-1252.
28. Radomski M.W., Palmer R.M., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990, 87:10043-10047.
29. Bove P.F., Van der Vliet A. Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic Biol Med 2006, 41:515-527.
30. Silko P.E., McClean P.A., Slutsky A.S., et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997, 155:260-267.
31. Silko P.E., Sylvester J.T., Zamel N., et al. Airway nitric oxide diffusion in asthma: role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 2000, 161:1218-1228.
32. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005, 171:912-930.
33. George S.C., Hogman M., Permutt S., et al. Modeling pulmonary nitric oxide exchange. J Appl Physiol 2004, 96:831-839.
34. Tsoukias N.M., George S.C. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998, 85:653-666. [see comment].
35. Paraskakis E., Brindicci C., Fleming L., et al. Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med 2006, 174:260-267.
36. Lehtimaki L., Kankaanranta H., Saarelainen S., et al. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001, 163:1557-1561.
37. Olivieri M., Talamini G., Corradi M., et al. Reference values for exhaled nitric oxide (REVENO) study. Respir Res 2006, 7:94.
38. Olin A.C., Alving K., Toren K. Exhaled nitric oxide: relation to sensitization and respiratory symptoms. Clin Exp Allergy 2004, 34:221-226.
39. Buchvald F., Baraldi E., Carraro S., et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005, 115:1130-1136.
40. Olin A.C., Rosengren A., Thelle D.S., et al. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006, 130(5):1319-1325.
41. Kovesi T., Kulka R., Dales R. Exhaled nitric oxide concentration is affected by age, height and race in healthy 9- to 12-year-old children. Chest 2008, 133:169-175.
42. Berlyne G.S., Parameswaran K., Kamada D., et al. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000, 106:638-644.
43. Jatakanon A., Lim S., Kharitonov S.A., et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998, 53:91-95.
44. Warke T.J., Fitch P.S., Brown V., et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002, 57:383-387.
45. Brightling C.E., Symon F.A., Birring S.S., et al. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003, 58:528-532.
46. Payne D.N., Adcock I.M., Wilson N.M., et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001, 164:1376-1381. [see comment].
47. van den Toorn L.M., Overbeek S.E., de Jongste J.C., et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001, 164:2107-2113. [published erratum appears in Am J Respir Crit Care Med 2002;166:1143].
48. Little S.A., Chalmers G.W., MacLeod K.J., et al. Noninvasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000, 55:232-234.
49. Smith A.D., Cowan J.O., Brassett K.P., et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005, 172:453-459.
50. Szefler S.J., Phillips B.R., Martinez F.D., et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005, 115:233-242. [see comment].
51. Pijnenburg M.W., Bakker E.M., Hop W.C., et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005, 172:831-836.
52. Katsara M., Donnelly D., Iqbal S., et al. Relationship between exhaled nitric oxide levels and compliance with inhaled corticosteroids in asthmatic children. Respir Med 2006, 100:1512-1517.
53. Kharitonov S.A., Yates D., Barnes P.J. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995, 8:295-297.
54. Carraro S., Andreola B., Alinova R., et al. Exhaled leukotriene B4 in children with community acquired pneumonia. Pediatr Pulmonol 2008, 43:982-986.
55. Papi A., Bellettato C.M., Braccioni F., et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006, 173:1114-1121.
56. Franklin P.J., Taplin R., Stick S.M. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 1999, 159:69-73.
57. Kissoon N., Duckworth L.J., Blake K.V., et al. Exhaled nitric oxide concentrations: online versus offline values in healthy children. Pediatr Pulmonol 2002, 33:283-292.
58. Tsang K.W., Ip S.K., Leung R., et al. Exhaled nitric oxide: the effects of age, gender and body size. Lung 2001, 179:83-91.
59. Chambers D.C., Tunnicliffe W.S., Ayres J.G. Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations. Thorax 1998, 53:677-679.
60. Horvath I., Donnelly L.E., Kiss A., et al. Exhaled nitric oxide and hydrogen peroxide concentrations in asthmatic smokers. Respiration 2004, 71:463-468.
61. Sont J.K., Han J., van Krieken J.M., et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996, 51:496-502.
62. Dupont L.J., Demedts M.G., Verleden G.M. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003, 123:751-756.
63. Smith A.D., Cowan J.O., Filsell S., et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004, 169:473-478.
64. Smith A.D., Taylor D.R. Is exhaled nitric oxide measurement a useful clinical test in asthma?. Curr Opin Allergy Clin Immunol 2005, 5:49-56.
65. Zietkowski Z., Bodzenta-Lukaszyk A., Tomasiak M.M., et al. Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients. J Investig Allergol Clin Immunol 2006, 16:239-246.
66. Alving K., Mailovschi A. Basic aspects of exhaled nitric oxide. Eur Respir Mon 2010, 49:1-31.
67. Delgado-Corcoran C., Kissoon N., Murphy S.P., et al. Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med 2004, 5:48-52.
68. Jatakanon A., Lim S., Barnes P.J. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000, 161:64-72.
69. Szefler S., Mitchell H., Sorkness C., et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomized controlled trial. Lancet 2008, 372:1065-1072.
70. Pijnenburg M., Bakker E., Lever S., et al. High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children. Clin Exp Allergy 2005, 35:920-925.
71. Buchvald F., Eiberg H., Bisgaard H. Heterogeneity of FeNO response to inhaled steroid in asthmatic children. Clin Exp Allergy 2003, 33:1735-1740.
72. Sont J.K., Willems L.N., Bel E.H., et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999, 159:1043-1051.
73. Green R.H., Brightling C.E., Woltmann G., et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002, 57:875-879.
74. van Veen I., Ten Brinke A., Sterk P., et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma. Eur Respir J 2008, 32:344-349.
75. Meyts I., Proesmans M., De Boeck K. Exhaled nitric oxide corresponds with office evaluation of asthma control. Pediatr Pulmonol 2003, 36:283-289.
76. Smith A.D., Cowan J.O., Brassett K.P., et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005, 352:2163-2173.
77. Corren J., Lemanske R., Hanania N., et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011, 365:1088-1098.
78. Haldar P., Brightling C., Hargadon B., et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009, 360:973-984.
79. Robbins R.A., Floreani A.A., Von Essen S.G., et al. Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med 1996, 153:1631-1635.
80. Corradi M., Majori M., Cacciani G.C., et al. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 1999, 54:572-575.
81. Bhowmilk A., Seemungal T.A., Donaldson G.C., et al. Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. Eur Respir J 2005, 26:1009-1015.
82. Maziak W., Loukides S., Culpitt S., et al. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:998-1002.
83. Rutgers S.R., van der Mark T.W., Coers W., et al. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax 1999, 54:576-580.
84. Jeffery P.K. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998, 53:129-136.
85. Ansarin K., Chatkin J.M., Ferreira I.M., et al. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. Eur Respir J 2001, 17:934-938.
86. Pedoto A., Caruso J.E., Nandi J., et al. Acidosis stimulates nitric oxide production and lung damage in rats. Am J Respir Crit Care Med 1999, 159:397-402.
87. Elphick H.E., Demoncheaux E.A., Ritson S., et al. Exhaled nitric oxide is reduced in infants with cystic fibrosis. Thorax 2001, 56:151-152.
88. Franklin P.J., Hall G.L., Moeller A., et al. Exhaled nitric oxide is not reduced in infants with cystic fibrosis. Eur Respir J 2006, 27:350-353.
89. Grasemann H., Michler E., Wallot M., et al. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 1997, 24:173-177.
90. Keen C., Olin A.C., Edenoft A., et al. Airway nitric oxide in patient with cystic fibrosis is associated with pancreatic function, pseudomonas infection, and polyunsaturated fatty acids. Chest 2007, 131:1857-1864.
91. Lundberg J.O., Nordvall S.L., Weitzberg E., et al. Exhaled NO in pediatric asthma and cystic fibrosis. Arch Dis Child 1996, 75:323-326.
92. Thomas S.R., Kharitonov S.A., Scott S.F., et al. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 2000, 117:1085-1089.
93. Armstrong D.S., Grimwood K., Carlin J.B., et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997, 156:1197-1204.
94. Grasemann H., Knauer N., Busher R., et al. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 2000, 162:2172-2176.
95. Tiev K.P., Cabane J., Aubourg F., et al. Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide. Eur Respir J 2007, 30:26-30.
96. Wilsher M.L., Fergusson W., Milne D., et al. Exhaled nitric oxide in sarcoidosis. Thorax 2005, 60:967-970.
97. Narang I., Ersu R., Wilson N.M., et al. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002, 57:586-589.
98. Horvath I., Loukides S., Wodehouse T., et al. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2003, 58:68-72.
99. Zihlif N., Paraskakis E., Lex C., et al. Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia. Pediatr Pulmonol 2005, 39:551-557.
100. Loukides S., Kharitonov S.A., Wodehouse T., et al. Effect of l-arginine on mucociliary function in primary ciliary dyskinesia. Lancet 1998, 352:371-372.
101. Kharitonov S.A., Lubec G., Lubec B., et al. l-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci 1995, 88:135-139.
102. Sundaresan S., Trulock E.P., Mohanakumar T., et al. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg 1995, 60:1341-1346.
103. Heng D., Sharples L.D., McNeil K., et al. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis and risk factors. J Heart Lung Transplant 1998, 17:1255-1263.
104. Brugiere O., Thabut G., Mal H., et al. Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome. Eur Respir J 2005, 25:813-819.